RCUS logo

Arcus Biosciences, Inc. (RCUS) Free cash flow

annual FCF:

-$176.00M+$154.00M(+46.67%)
December 31, 2024

Summary

  • As of today (September 16, 2025), RCUS annual free cash flow is -$176.00 million, with the most recent change of +$154.00 million (+46.67%) on December 31, 2024.
  • During the last 3 years, RCUS annual FCF has risen by +$106.00 million (+37.59%).
  • RCUS annual FCF is now -140.74% below its all-time high of $432.00 million, reached on December 31, 2022.

Performance

RCUS Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRCUScash flow metrics

quarterly FCF:

-$133.00M$0.00(0.00%)
June 30, 2025

Summary

  • As of today (September 16, 2025), RCUS quarterly free cash flow is -$133.00 million, unchanged on June 30, 2025.
  • Over the past year, RCUS quarterly FCF has dropped by -$39.00 million (-41.49%).
  • RCUS quarterly FCF is now -120.43% below its all-time high of $651.00 million, reached on March 31, 2022.

Performance

RCUS quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRCUScash flow metrics

TTM FCF:

-$342.00M-$39.00M(-12.87%)
June 30, 2025

Summary

  • As of today (September 16, 2025), RCUS TTM free cash flow is -$342.00 million, with the most recent change of -$39.00 million (-12.87%) on June 30, 2025.
  • Over the past year, RCUS TTM FCF has dropped by -$75.00 million (-28.09%).
  • RCUS TTM FCF is now -176.51% below its all-time high of $447.02 million, reached on June 30, 2022.

Performance

RCUS TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRCUScash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

RCUS Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+46.7%-41.5%-28.1%
3 y3 years+37.6%-84.7%-176.5%
5 y5 years-133.5%-449.7%-266.6%

RCUS Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-140.7%+46.7%-632.0%at low-176.5%at low
5 y5-year-140.7%+46.7%-120.4%at low-176.5%at low
alltimeall time-140.7%+46.7%-120.4%at low-176.5%at low

RCUS Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$133.00M(0.0%)
-$342.00M(+12.9%)
Mar 2025
-
-$133.00M(+31.7%)
-$303.00M(+72.2%)
Dec 2024
-$176.00M(-46.7%)
-$101.00M(-504.0%)
-$176.00M(+4.1%)
Sep 2024
-
$25.00M(-126.6%)
-$169.00M(-36.7%)
Jun 2024
-
-$94.00M(+1466.7%)
-$267.00M(+13.6%)
Mar 2024
-
-$6.00M(-93.6%)
-$235.00M(-28.8%)
Dec 2023
-$330.00M(-176.4%)
-$94.00M(+28.8%)
-$330.00M(+10.0%)
Sep 2023
-
-$73.00M(+17.7%)
-$300.00M(-3.2%)
Jun 2023
-
-$62.00M(-38.6%)
-$310.00M(-3.1%)
Mar 2023
-
-$101.00M(+57.8%)
-$320.00M(-174.1%)
Dec 2022
$432.00M(-253.2%)
-$64.00M(-22.9%)
$432.00M(+1.5%)
Sep 2022
-
-$83.00M(+15.3%)
$425.64M(-4.8%)
Jun 2022
-
-$72.00M(-111.1%)
$447.02M(+1.8%)
Mar 2022
-
$651.00M(-1025.2%)
$438.96M(-255.7%)
Dec 2021
-$282.00M
-$70.36M(+14.2%)
-$282.00M(+7.2%)
Sep 2021
-
-$61.62M(-23.0%)
-$263.15M(-2027.2%)
Jun 2021
-
-$80.07M(+14.5%)
$13.65M(-80.4%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$69.96M(+35.8%)
$69.53M(-35.6%)
Dec 2020
$108.00M(-243.3%)
-$51.51M(-123.9%)
$108.00M(-27.9%)
Sep 2020
-
$215.19M(-989.5%)
$149.85M(-260.6%)
Jun 2020
-
-$24.19M(-23.2%)
-$93.30M(+4.4%)
Mar 2020
-
-$31.49M(+225.7%)
-$89.41M(+18.6%)
Dec 2019
-$75.39M(+61.3%)
-$9.67M(-65.4%)
-$75.39M(+3.1%)
Sep 2019
-
-$27.95M(+37.7%)
-$73.08M(+25.9%)
Jun 2019
-
-$20.30M(+16.2%)
-$58.03M(+16.3%)
Mar 2019
-
-$17.47M(+137.2%)
-$49.91M(+6.8%)
Dec 2018
-$46.74M(+52.9%)
-$7.37M(-42.9%)
-$46.74M(+94.1%)
Sep 2018
-
-$12.89M(+5.8%)
-$24.08M(-33.6%)
Jun 2018
-
-$12.18M(-14.8%)
-$36.26M(+9.4%)
Mar 2018
-
-$14.30M(-193.5%)
-$33.14M(+8.4%)
Dec 2017
-$30.57M(+79.4%)
$15.29M(-161.0%)
-$30.57M(-33.3%)
Sep 2017
-
-$25.07M(+176.8%)
-$45.87M(+120.6%)
Jun 2017
-
-$9.06M(-22.8%)
-$20.79M(+77.2%)
Mar 2017
-
-$11.74M
-$11.74M
Dec 2016
-$17.04M
-
-

FAQ

  • What is Arcus Biosciences, Inc. annual free cash flow?
  • What is the all time high annual FCF for Arcus Biosciences, Inc.?
  • What is Arcus Biosciences, Inc. annual FCF year-on-year change?
  • What is Arcus Biosciences, Inc. quarterly free cash flow?
  • What is the all time high quarterly FCF for Arcus Biosciences, Inc.?
  • What is Arcus Biosciences, Inc. quarterly FCF year-on-year change?
  • What is Arcus Biosciences, Inc. TTM free cash flow?
  • What is the all time high TTM FCF for Arcus Biosciences, Inc.?
  • What is Arcus Biosciences, Inc. TTM FCF year-on-year change?

What is Arcus Biosciences, Inc. annual free cash flow?

The current annual FCF of RCUS is -$176.00M

What is the all time high annual FCF for Arcus Biosciences, Inc.?

Arcus Biosciences, Inc. all-time high annual free cash flow is $432.00M

What is Arcus Biosciences, Inc. annual FCF year-on-year change?

Over the past year, RCUS annual free cash flow has changed by +$154.00M (+46.67%)

What is Arcus Biosciences, Inc. quarterly free cash flow?

The current quarterly FCF of RCUS is -$133.00M

What is the all time high quarterly FCF for Arcus Biosciences, Inc.?

Arcus Biosciences, Inc. all-time high quarterly free cash flow is $651.00M

What is Arcus Biosciences, Inc. quarterly FCF year-on-year change?

Over the past year, RCUS quarterly free cash flow has changed by -$39.00M (-41.49%)

What is Arcus Biosciences, Inc. TTM free cash flow?

The current TTM FCF of RCUS is -$342.00M

What is the all time high TTM FCF for Arcus Biosciences, Inc.?

Arcus Biosciences, Inc. all-time high TTM free cash flow is $447.02M

What is Arcus Biosciences, Inc. TTM FCF year-on-year change?

Over the past year, RCUS TTM free cash flow has changed by -$75.00M (-28.09%)
On this page